“Rapid Itch Relief with Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Results from the Phase 3b/4 Level Up Study” (2026) SKIN The Journal of Cutaneous Medicine, 10(2), p. s735. doi:10.25251/078a3s70.